View in EDS HTML Full Text PDF Full Text

A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.

Saved in:
Bibliographic Details
Title: A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.
Authors: Ye, Zhengyu1,2 (AUTHOR), Dai, Wenhao3,4 (AUTHOR), Zhang, Shaolin5,6 (AUTHOR), Xiang, Yingchun5,6 (AUTHOR), Wang, Jinlin3 (AUTHOR), Zhang, Yumin1,2 (AUTHOR), Cao, Wenyuan5,6 (AUTHOR), Neyts, Johan7 (AUTHOR), Li, Zuyi8 (AUTHOR), Feng, Fan1,9 (AUTHOR), Xiao, Gengfu1,2 (AUTHOR), Liu, Hong3,4 (AUTHOR) hliu@simm.ac.cn, Cao, Junyuan1,2 (AUTHOR) caojunyuan@wh.iov.cn, Zhang, Lei-ke1,2,6 (AUTHOR) zhangleike@wh.iov.cn
Source: PLoS Pathogens. 3/11/2026, Vol. 22 Issue 3, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1014051